Abstract:
OBJECTIVE To explore the risk factors of pulmonary infections in patients with cerebral infarction, and to analyze and summarize the relevant nursing strategies.
METHODS A total of 340 patients with cerebral infarction diagnosed from Apr. 2015 to Apr. 2017 were selected as the subjects. According to the different nursing methods, they were divided into control group and observation group, with 170 cases in each group. Patients in observation group received holistic nursing, and in control group were given routine nursing intervention. Hospitalization time, nursing satisfaction, immune function and inflammatory markers were compared between the two groups after nursing intervention. The situation of cerebral infarction complicated with pulmonary infections was observed, and the related risk factors were analyzed.
RESULTS Among 340 patients with cerebral infarction, 63 patients had postoperative infections, with the infection rate of 18.53%. The incidence of pulmonary infections in patients with cerebral infarction was correlated with age, GCS score, history of diabetes mellitus, history of smoking, complications, and use of antimicrobial agents and hormones(
P<0.05), and aseptic operation was the protective factor (
P<0.05). The hospitalization time, hs-CRP, IL-6, IL-8 and WBC in observation group were (12.05±5.56) d, (5.59±2.61) mg/L, (9.53±1.03) ng/L, (7.17±1.43) ng/L and (8.01 ± 2.11)/L, which were lower than those in control group(19.96±5.23) d, (7.71±3.37) mg/L, (12.45±1.16) ng/L, (10.59±1.69) ng/L and (10.23±2.57)/L, and the differences were significant (
P<0.001). The observation group with the nursing satisfaction, CD
4,CD
8,CD
4/CD
8 were 94.12%, (37.24±8.03)%, (22.72±7.18)% and (1.67±0.73), which were significantly better than those in control group78.82%, (30.73 ± 8.87)%, (27.18 ± 7.36)% and (1.15±0.58) (
P<0.001).
CONCLUSION In the clinical treatment and nursing of patients with cerebral infarction, we should give the appropriate care measures according to the above risk factors to reduce the incidence of pulmonary infections and improve the effect of clinical treatment.